Intraocular pressure reducing 11-acyl prostaglandins

Details Intraocular pressure reducing 11-acyl prostaglandins Intraocular pressure reducing 11-acyl prostaglandins

1990-10-10

1995-08-29

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514546, 514549, 514552, 514913, A61K 31215, A61K 3123, A61K 3122

Patent

active

054460417

ABSTRACT:
Disclosed is an intraocular pressure reducing method and composition wherein 11-acyl prostaglandins are contained in a pharmaceutically acceptable excipient for topical application to the surface of the eye.

REFERENCES:
patent: 4001306 (1977-01-01), Morozowich et al.
patent: 4060540 (1977-11-01), Bernady et al.
patent: 4822819 (1989-04-01), DeSantis et al.
patent: 4824857 (1989-04-01), Goh et al.
patent: 4883819 (1989-11-01), Bito II
Starr, Exp. Eye Res. 11, 170-177 (1971).
Zajacz et al., The Eye: Reproduction, Obstetrics and Gynecology 4, 316 (1976).
Keun Kim Investigative Ophthalmology 14, 36 (1975).
Camras et al., Invest. Ophthalmol. Visual Sci. 16, 1125 (1977).
Woodward et al., Invest. Ophthalmol. Visual Sci. 30, 1838 (1989).
Nilsson et al., Exp. Eye Res. 48, 707 (1989).
Bito, Arch. Ophthalmol. 105, 1036 (1987).
Siebold et al., Prodrug 5, 3 (1989).
Carmely, S. and Kashman, Y., Tetrahedron Letters 21:875-878 (1980).

Affiliated with

Also associated with

Rating

Intraocular pressure reducing 11-acyl prostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraocular pressure reducing 11-acyl prostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular pressure reducing 11-acyl prostaglandins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1819571